American Century Companies’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.17M | Buy |
|
|||||
|
2025
Q2 | $854K | Buy |
|
|||||
|
2025
Q1 | $593K | Sell |
|
|||||
|
2024
Q4 | $687K | Sell |
|
|||||
|
2024
Q3 | $860K | Sell |
|
|||||
|
2024
Q2 | $994K | Buy |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $920K | Buy |
|
|||||
|
2023
Q3 | $623K | Buy |
|
|||||
|
2023
Q2 | $702K | Buy |
|
|||||
|
2023
Q1 | $529K | Buy |
|
|||||
|
2022
Q4 | $426K | Buy |
|
|||||
|
2022
Q3 | $570K | Sell |
|
|||||
|
2022
Q2 | $12.7M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $28.5M | Sell |
|
|||||
|
2021
Q3 | $42.2M | Sell |
|
|||||
|
2021
Q2 | $61M | Buy |
|
|||||
|
2021
Q1 | $34M | Sell |
|
|||||
|
2020
Q4 | $55.5M | Sell |
|
|||||
|
2020
Q3 | $56.9M | Buy |
|
|||||
|
2020
Q2 | $35.3M | Buy |
|
|||||
|
2020
Q1 | $4.92M | Buy |
|